Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study

NCT02184689 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
125
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Drugs for Neglected Diseases